Private Equity in Healthcare: A Growing Force Reshaping the Industry
Global healthcare private equity deal value reached an estimated $115 billion in 2024, the second-highest total on record, propelled by five transactions exceeding $5 billion each. The Healthcare Private Equity Association (HCPEA) reports its member firms manage over $4 trillion in assets with investments in more than 1,500 companies.
Where PE Capital Is Flowing
| Subsector | Deal Activity | Key Drivers |
|---|---|---|
| Physician Practices | High | Urgent care, dermatology, dental, cardiology roll-ups |
| Healthcare IT | Very High | Revenue cycle, workflow automation, patient engagement |
| Life Sciences Services | High | CROs, CDMOs, specialty distribution |
| Behavioral Health | Growing | Substance use, autism services, mental health platforms |
| Post-Acute & Home Health | Steady | Aging demographics, value-based care shift |
Who Are the Major Buyers?
The top tier of healthcare-focused PE firms deploy billions annually across the sector:
- Apollo Global Management
- Owns approximately 220 hospitals across 36 states through LifePoint Health and Scion. Completed the $5.6B LifePoint acquisition in 2018.
- KKR
- Invested over $20 billion of equity in healthcare since 2004. Recently acquired HealthCare Royalty Partners (HCRx) to expand its life sciences strategy.
- Welsh, Carson, Anderson & Stowe
- Invested more than $11 billion in 100+ healthcare companies. Current portfolio of approximately 30 companies spanning payor services, healthcare delivery, and medtech.
- TPG Capital
- Maintains 13 active healthcare portfolio companies including next-generation care delivery platforms like LifeStance and Monogram Health.
Deal Size Trends
The mega-deal is back. Sycamore Partners finalized a $22+ billion acquisition of Walgreens in August 2025, immediately splitting the company into five standalone businesses. The Medline Industries buyout by Blackstone, Carlyle, and Hellman & Friedman for $34 billion remains one of the largest LBOs of the decade, with an IPO now being prepared at a potential $50 billion valuation.